The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index; none of the 5 sources its claims cite is checked for support yet.
Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality
Open accessAbstract
BACKGROUND: Global deaths from cardiovascular disease are increasing as a result of population growth, the aging of populations, and epidemiologic changes in disease. Disentangling the effects of these three drivers on trends in mortality is important for planning the future of the health care system and benchmarking progress toward the reduction of cardiovascular disease. METHODS: We used mortality data from the Global Burden of Disease Study 2013, which includes data on 188 countries grouped into 21 world regions. We developed three counterfactual scenarios to represent the principal drivers of change in cardiovascular deaths (population growth alone, population growth and aging, and epidemiologic changes in disease) from 1990 to 2013. Secular trends and correlations with changes in national income were examined. RESULTS: Global deaths from cardiovascular disease increased by 41% between 1990 and 2013 despite a 39% decrease in age-specific death rates; this increase was driven by a 55% increase in mortality due to the aging of populations and a 25% increase due to population growth. The relative contributions of these drivers varied by region; only in Central Europe and Western Europe did the annual number of deaths from cardiovascular disease actually decline. Change in gross domestic product per capita was correlated with change in age-specific death rates only among upper-middle income countries, and this correlation was weak; there was no significant correlation elsewhere. CONCLUSIONS: The aging and growth of the population resulted in an increase in global cardiovascular deaths between 1990 and 2013, despite a decrease in age-specific death rates in most regions. Only Central and Western Europe had gains in cardiovascular health that were sufficient to offset these demographic forces. (Funded by the Bill and Melinda Gates Foundation and others.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 5 cited sources checked · 0 supported · 0 flagged
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For the most common cause of cardiovascular death, ischemic heart disease, the number of deaths increased by an estimated 41.7% from 1990 to 2013.”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > DISCUSSION
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Even larger declines (more than 55%) were seen as a result of epidemiologic changes in the risk of hemorrhagic stroke.”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > RESULTS > GLOBAL DEATHS DUE TO CARDIOVASCULAR DISEASES
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“According to our estimates, epidemiologic change led to an increase in cardiovascular deaths in only one region of the world (western sub-Saharan Africa).”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > RESULTS > CARDIOVASCULAR DEATHS ACCORDING TO REGION
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The combination of increases in the number of deaths due to population growth and population aging and declines in age-specific death rates represented the most common epidemiologic profile among the specific cardiovascular causes of death (Table 1).”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > RESULTS > GLOBAL DEATHS DUE TO CARDIOVASCULAR DISEASES
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“whereas population growth contributed to an estimated 23.6% increase.”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > DISCUSSION
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Rheumatic heart disease was the only cardiovascular condition for which there were fewer total deaths globally in 2013 than in 1990.”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > RESULTS > GLOBAL DEATHS DUE TO CARDIOVASCULAR DISEASES
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Ischemic heart disease was the largest contributor to the increase in the number of cardiovascular deaths (2.4 million of the overall increase of 5.0 million cardiovascular deaths)”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > RESULTS > GLOBAL DEATHS DUE TO CARDIOVASCULAR DISEASES
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Central Europe and Western Europe, which had declines of an estimated 5.2% and 12.8%, respectively.”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > RESULTS > CARDIOVASCULAR DEATHS ACCORDING TO REGION
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“East Asia reported more than 1.2 million additional deaths in 2013, representing a 47.2% increase from 1990.”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > RESULTS > CARDIOVASCULAR DEATHS ACCORDING TO REGION
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“only in Central Europe and Western Europe did the annual number of deaths from cardiovascular disease actually decline.”
- Also stated in: § CARDIOVASCULAR DEATHS ACCORDING TO REGION · plain
“The only regions with a significant decrease in cardiovascular deaths were Central Europe and Western Europe, which had declines of an estimated 5.2% and 12.8%, respectively.”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > Abstract > RESULTS
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Also stated in: § CARDIOVASCULAR DEATHS ACCORDING TO REGION · plain
- It may state two separate claims as one. 10
- The quote only partly states this claim. 1
- Probably not a substantial claim. 8
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Change in gross domestic product per capita was correlated with change in age-specific death rates only among upper-middle income countries, and this correlation was weak; there was no significant correlation elsewhere.”
- Also stated in: § CARDIOVASCULAR DEATHS AND NATIONAL INCOME PER CAPITA · plain
“the two variables had a significant correlation only within the category of upper-middle income.”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > Abstract > RESULTS
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Also stated in: § CARDIOVASCULAR DEATHS AND NATIONAL INCOME PER CAPITA · plain
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Southern Latin America, Australasia, and high-income North America had no detectable change in the number of deaths from 1990 to 2013 (as indicated by an uncertainty interval crossing 0) because population aging and growth balanced out declines in age-specific death rates.”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > RESULTS > CARDIOVASCULAR DEATHS ACCORDING TO REGION
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Atrial fibrillation or flutter and peripheral vascular disease are notable exceptions to the demographic and epidemiologic pattern for cardiovascular disease. Deaths from each of these conditions increased dramatically between 1990 and 2013, driven not only by population growth and aging but also by increases in age- and sex-specific death rates.”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > RESULTS > GLOBAL DEATHS DUE TO CARDIOVASCULAR DISEASES
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In absolute terms, South Asia had the largest estimated increase in deaths from cardiovascular disease, reporting more than 1.7 million more deaths in 2013 than in 1990. This change represents an increase of 97.4% (95% uncertainty interval, 72 to 126.1).”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > RESULTS > CARDIOVASCULAR DEATHS ACCORDING TO REGION
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For example, there were 349,153 cardiovascular deaths in the high-income Asia–Pacific region in 1990. In 2013, there were 487,170 cardiovascular deaths, which is less than the 910,042 that would have been expected if 1990 death rates had remained constant, given the population size and the age structure in that region in 2013.”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > METHODS > DETERMINATION OF DRIVERS OF CARDIOVASCULAR MORTALITY
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Most countries had an increase in income per capita and a decline in the number of cardiovascular deaths due to epidemiologic change.”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > RESULTS > CARDIOVASCULAR DEATHS AND NATIONAL INCOME PER CAPITA
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“despite a 39% decrease in age-specific death rates”
- Also stated in: § GLOBAL DEATHS DUE TO CARDIOVASCULAR DISEASES · plain
“despite a decrease in deaths attributable to epidemiologic changes of 39.3% (95% uncertainty interval, 33.6 to 44.1)”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > Abstract > RESULTS
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe quote only partly states this claim.
- Also stated in: § GLOBAL DEATHS DUE TO CARDIOVASCULAR DISEASES · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This pattern was also present in trends for ischemic heart disease, ischemic stroke, hemorrhagic and other nonischemic causes of stroke, hypertensive heart disease, cardiomyopathy, myocarditis, aortic aneurysm, and endocarditis.”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > RESULTS > GLOBAL DEATHS DUE TO CARDIOVASCULAR DISEASES
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“These changes are probably due to the combined effect of birth cohorts’ decreased exposure to tobacco smoking, improvements in diet, and improved treatment of cardiovascular disease and cardio-metabolic risk factors targeting the prevention of cardiovascular disease, and improved treatment of cardiovascular disease.10”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > DISCUSSION
What the sources say
- Not checked yetcites [10] source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In contrast, South Asia had a dramatic rise in cardiovascular deaths due to population growth and aging without a significant decline in cardiovascular deaths due to epidemiologic change.”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > DISCUSSION
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“However, the rigorous out-of-sample predictive validity testing used in GBD 2013 is cause for some confidence.”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > DISCUSSION
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“As they have noted, the classic model of “epidemiologic transition” does not fully reflect the heterogeneity of the burden of cardiovascular disease across countries.”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > DISCUSSION
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“A deterministic health policy model indicated that 40 to 55% of the decline in coronary heart disease in high-income countries can be attributed to the effects of medical and surgical treatments.12”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > DISCUSSION
What the sources say
- Not checked yetcites [12] source
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Finally, we recognize that patterns of disease burden vary not just between but also within countries. Any summary provided at the level of a region or country may mask significant disparities within that area.”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > DISCUSSION
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds. It may state two separate claims as one.
In the paper
“However, calculations made with the traditional Shapley method and other methods used in econometrics may produce different results.6”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > DISCUSSION
What the sources say
- Not checked yetcites [6] source
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“First, cause-specific mortality data are lacking or of limited quality in some countries.”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > DISCUSSION
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Similarly, the number of deaths resulting from rheumatic heart disease may not be completely captured by vital records in regions in which the condition is endemic.”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > DISCUSSION
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Furthermore, the remarkable increase in the age-specific rate of death from atrial fibrillation probably reflects increases in the screening, recognition, and attribution of death to atrial fibrillation in addition to changes in disease epidemiology.”
§ Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality > DISCUSSION
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ageing of the population also contributes to increasing the absolute number of CVD events. 17”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [17]
In the citing paper
“Ageing of the population also contributes to increasing the absolute number of CVD events.17”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [17]
Citations
Cites
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Self-citationExplaining the decrease in U.S. deaths from coronary disease, 1980–2000
Ford, E. S., Ajani, U. A., Croft, J. B., Critchley, J. A., Labarthe, D. R., Kottke, T. E., Giles, W. H., & Capewell, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmsa053935 · Cited by 2,757
Universal Definition of Myocardial Infarction: Clinical Insights
Paiva, L., Providencia, R. A., Barra, S., Dinis, P., Faustino, C., & Gonçalves, L. M. M. (2015) · Cardiology · doi:10.1159/000371739 · Cited by 2,513
Smoking prevalence and cigarette consumption in 187 countries, 1980-2012
Ng, M., Freeman, M. K., Fleming, T. D., Robinson, M., Dwyer-Lindgren, L., Thomson, B., Wollum, A., Sanman, E., Wulf, S., Lopez, A. D., et al. (2014) · JAMA · doi:10.1001/jama.2013.284692 · Cited by 1,576
Self-citationEmerging Epidemic of Cardiovascular Disease in Developing Countries
Reddy, K. S., & Yusuf, S. (1998) · Circulation · doi:10.1161/01.cir.97.6.596 · Cited by 1,206
Decomposition procedures for distributional analysis: a unified framework based on the Shapley value
Shorrocks, A. F. (2013) · The Journal of Economic Inequality · doi:10.1007/s10888-011-9214-z · Cited by 1,190
Yusuf, S., Reddy, S., Ôunpuu, S., & Anand, S. (2001) · Circulation · doi:10.1161/hc4701.099488 · Cited by 1,141
Ezzati, M., Hoorn, S. V., Lawes, C. M. M., Leach, R. J., James, W. P. T., López, A. D., Rodgers, A., & Murray, C. J. L. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020133 · Cited by 627
Self-citationModeling causes of death: an integrated approach using CODEm
Foreman, K. J., Lozano, R., Lopez, A. D., & Murray, C. J. (2012) · Population Health Metrics · doi:10.1186/1478-7954-10-1 · Cited by 564
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- GBD 2013 Mortality and Causes of Death Collaborators, 2014, Lancet, 385, 117
Cited by
Sorted by citations
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2021) · PubMed · doi:10.1093/eurheartj/ehab670 · Cited by 20,604
2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Self-citationGlobal Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
Roth, G. A., Mensah, G. A., Johnson, C. O., Addolorato, G., Ammirati, E., Baddour, L. M., Barengo, N. C., Beaton, A. Z., Benjamin, E. J., Benziger, C. P., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.010 · Cited by 11,449
Self-citationMach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961
Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., Das, S. R., de Ferranti, S., Després, J.-P., Fullerton, H. J., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000350 · Cited by 6,596
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw106 · Cited by 6,457
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.08.014 · Cited by 4,854
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw272 · Cited by 3,162
2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Authors/Task Force Members:, McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2333 · Cited by 2,356
Feigin, V. L., Abate, M. D., Abate, Y. H., ElHafeez, S. A., Abd-Allah, F., Abdelalim, A., Abdelkader, A. F. I., Abdelmasseh, M., Abd-Elsalam, S. M., Abdi, P., et al. (2024) · The Lancet Neurology · doi:10.1016/s1474-4422(24)00369-7 · Cited by 2,060
Self-citationGroenewegen, A., Rutten, F. H., Mosterd, A., & Hoes, A. W. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1858 · Cited by 2,043
Epidemiology and aetiology of heart failure
Ziaeian, B., & Fonarow, G. C. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.25 · Cited by 1,976
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.08.018 · Cited by 1,582
Periodontitis and cardiovascular diseases: Consensus report
Sanz, M., Marco del Castillo, A., Jepsen, S., Gonzalez‐Juanatey, J. R., D’Aiuto, F., Bouchard, P., Chapple, I., Dietrich, T., Gotsman, I., Graziani, F., et al. (2020) · Journal of Clinical Periodontology · doi:10.1111/jcpe.13189 · Cited by 1,482
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Authors/Task Force Members, Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M. T., Corrà, U., Cosyns, B., et al. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316653709 · Cited by 1,435
Lear, S. A., Hu, W., Rangarajan, S., Gasevic, D., Leong, D., Iqbal, R., Casanova, A., Swaminathan, S., Anjana, R. M., Kumar, R., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31634-3 · Cited by 1,331
Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013: The GBD 2013 Study
Feigin, V. L., Krishnamurthi, R., Parmar, P. G. K., Norrving, B., Mensah, G. A., Bennett, D., Barker-Collo, S. L., Moran, A. E., Sacco, R. L., Truelsen, T., et al. (2015) · Neuroepidemiology · doi:10.1159/000441085 · Cited by 1,342
Self-citationAge and Age-Related Diseases: Role of Inflammation Triggers and Cytokines
Rea, I. M., Gibson, D. S., McGilligan, V., McNerlan, S. E., Alexander, H. D., & Ross, O. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00586 · Cited by 1,267
Reducing the Global Burden of Cardiovascular Disease, Part 1
Joseph, P. G., Leong, D. P., McKee, M., Anand, S. S., Schwalm, J.-D., Teo, K. K., Mente, A., & Yusuf, S. (2017) · Circulation Research · doi:10.1161/circresaha.117.308903 · Cited by 1,135
European Society of Cardiology: Cardiovascular Disease Statistics 2017
Timmis, A., Petersen, S. E., Belle, E. V., Townsend, N. P., Conrad, N., Kapłon‐Cieślicka, A., Kazakiewicz, D., Kavousi, M., Cvijić, M., Ignatiuk, B., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehag345 · Cited by 1,001
Global and Regional Patterns in Cardiovascular Mortality From 1990 to 2013
Roth, G. A., Huffman, M. D., Moran, A. E., Feigin, V. L., Mensah, G. A., Naghavi, M., & Murray, C. J. L. (2015) · Circulation · doi:10.1161/circulationaha.114.008720 · Cited by 908
Self-citationCardiovascular Effects and Benefits of Exercise
Nystoriak, M. A., & Bhatnagar, A. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00135 · Cited by 968
Epidemiology of Diabetes Mellitus and Cardiovascular Disease
Glovaci, D., Fan, W., & Wong, N. D. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1107-y · Cited by 764
Peker, Y., Glantz, H., Eulenburg, C., Wegscheider, K., Herlitz, J., & Thunström, E. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201601-0088oc · Cited by 756
Global Overview of the Epidemiology of Atherosclerotic Cardiovascular Disease
Barquera, S., Pedroza-Tobías, A., Medina, C., Hernández-Barrera, L., Bibbins-Domingo, K. B., Lozano, R., & Moran, A. E. (2015) · Archives of Medical Research · doi:10.1016/j.arcmed.2015.06.006 · Cited by 746
Self-citationPopulation ageing and mortality during 1990–2017: A global decomposition analysis
Cheng, X., Yang, Y., Schwebel, D. C., Liu, Z., Li, L., Cheng, P., Ning, P., & Hu, G. (2020) · PLoS Medicine · doi:10.1371/journal.pmed.1003138 · Cited by 535
Homocysteine lowering interventions for preventing cardiovascular events
Martí-Carvajal, A. J., Solà, I., Lathyris, D., & Salanti, G. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006612.pub2 · Cited by 520
Global epidemiology and future trends of heart failure
Lippi, G., & Sanchis‐Gomar, F. (2020) · AME Medical Journal · doi:10.21037/amj.2020.03.03 · Cited by 507
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M. T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.05.037 · Cited by 502
GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
Zhao, X., Wang, M., Wen, Z., Lu, Z., Cui, L., Fu, C., Xue, H., Liu, Y., & Zhang, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.721135 · Cited by 463
Global Atlas of Cardiovascular Disease 2000-2016: The Path to Prevention and Control
Thomas, H., Diamond, J. E., Vieco, A., Chaudhuri, S., Shinnar, E., CROMER, S. J., Perel, P., Mensah, G. A., Narula, J., Johnson, C. O., et al. (2018) · Global Heart · doi:10.1016/j.gheart.2018.09.511 · Cited by 440
Self-citationBlood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease
Yusuf, S., Lonn, E., Pais, P. S., Bosch, J., López-Jaramillo, P. A., Zhu, J., Xavier, D., Avezum, Á., Leiter, L. A., Piegas, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1600177 · Cited by 380
Emerging Role of Precision Medicine in Cardiovascular Disease
Leopold, J. A., & Loscalzo, J. (2018) · Circulation Research · doi:10.1161/circresaha.117.310782 · Cited by 380
Cardiovascular Health in Brazil
Ribeiro, A. L. P., Duncan, B. B., Brant, L. C. C., Lotufo, P. A., Mill, J. G., & Barreto, S. M. (2016) · Circulation · doi:10.1161/circulationaha.114.008727 · Cited by 374
Normalization of NAD + Redox Balance as a Therapy for Heart Failure
Lee, C. F., Chavez, J. D., Garcia‐Menendez, L., Choi, Y. S., Roe, N. D., Chiao, Y. A., Edgar, J. S., Goo, Y. A., Goodlett, D. R., Bruce, J. E., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.022495 · Cited by 342
Mensah, G., Roth, G., Sampson, U. K. A., Moran, A., Feigin, V. L., Forouzanfar, M., Naghavi, M., & Cjl, M. (2015) · Cardiovascular journal of South Africa/Cardiovascular journal of Southern Africa · doi:10.5830/cvja-2015-036 · Cited by 336
Self-citationon behalf of the China Kadoorie Biobank Collaborative Group, Sun, L., Clarke, R., Bennett, D., Yu, C., Walters, R. G., Hill, M., Parish, S., Millwood, I. Y., Bian, Z., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0366-x · Cited by 318
Fifteen new risk loci for coronary artery disease highlight arterial-wall-specific mechanisms
CARDIoGRAMplusC4D, Howson, J. M. M., EPIC-CVD, Zhao, W., Barnes, D. R., Ho, W.-K., Young, R., Paul, D. S., Waite, L. L., Freitag, D. F., et al. (2017) · Nature Genetics · doi:10.1038/ng.3874 · Cited by 309
Periodontitis and Cardiovascular Diseases. Consensus Report
Sanz, M., Castillo, A. M. D., Jepsen, S. V., González‐Juanatey, J. R., D’Aiuto, F., Bouchard, P., Chapple, I., Dietrich, T., Gotsman, I., Graziani, F., et al. (2020) · Global Heart · doi:10.5334/gh.400 · Cited by 294
Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target
Behbodikhah, J., Ahmed, S., Elyasi, A., Kasselman, L. J., Leon, J. D., Glass, A. D., & Reiss, A. B. (2021) · Metabolites · doi:10.3390/metabo11100690 · Cited by 299
Homocysteine-lowering interventions for preventing cardiovascular events
Martí-Carvajal, A. J., Solà, I., Lathyris, D., & Dayer, M. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006612.pub5 · Cited by 295
Bollyky, T. J., Templin, T., Cohen, M., & Dieleman, J. L. (2017) · Health Affairs · doi:10.1377/hlthaff.2017.0708 · Cited by 282
Epidemiology, Pathophysiology, and Prognosis of Heart Failure in Older Adults
Dharmarajan, K., & Rich, M. W. (2017) · Heart Failure Clinics · doi:10.1016/j.hfc.2017.02.001 · Cited by 291
Fiolet, A. T. L., Opstal, T. S. J., Mosterd, A., Eikelboom, J. W., Jolly, S. S., KEECH, A. C., Kelly, P. J., Tong, D. C., Layland, J. J., Nidorf, S. M., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab115 · Cited by 263
Resistance Exercise Training as a Primary Countermeasure to Age-Related Chronic Disease
Mcleod, J. C., Stokes, T., & Phillips, S. M. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00645 · Cited by 254
Yan, T., Zhu, S., Yin, X., Xie, C., Xue, J., Zhu, M., Weng, F., Zhu, S., Xiang, B., Zhou, X., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.027852 · Cited by 253
Prevention of stroke: a strategic global imperative
Feigin, V. L., Norrving, B., George, M. G., Foltz, J. L., Roth, G. A., & Mensah, G. A. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.107 · Cited by 250
Self-citationPeptides as Therapeutic Agents: Challenges and Opportunities in the Green Transition Era
Rossino, G., Marchese, E., Galli, G., Verde, F., Finizio, M., Serra, M., Linciano, P., & Collina, S. (2023) · Molecules · doi:10.3390/molecules28207165 · Cited by 257
Mentkowski, K. I., & Lang, J. K. (2019) · Scientific Reports · doi:10.1038/s41598-019-46407-1 · Cited by 244
Cardiometabolic-Based Chronic Disease, Adiposity and Dysglycemia Drivers
Mechanick, J. I., Farkouh, M. E., Newman, J. D., & Garvey, W. T. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.11.044 · Cited by 243
Epidemiology in diabetes mellitus and cardiovascular disease
Fan, W. (2017) · Cardiovascular Endocrinology · doi:10.1097/xce.0000000000000116 · Cited by 249
Jung, S., Hwang, B., Shin, S. Y., Park, E., Park, S., Kim, C. W., Kim, E., Choo, E. H., Choi, I. J., Świrski, F. K., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32284-2 · Cited by 219
Rosoff, D. B., Smith, G. D., Mehta, N. N., Clarke, T., & Lohoff, F. W. (2020) · PLoS Medicine · doi:10.1371/journal.pmed.1003410 · Cited by 213
Unmet Need for Adjunctive Dyslipidemia Therapy in Hypertriglyceridemia Management
Ganda, O. P., Bhatt, D. L., Mason, R. P., Miller, M., & Boden, W. E. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.04.061 · Cited by 195
Won, K., Park, E. J., Han, D., Lee, J. H., Choi, S., Chun, E. J., Park, S. H., Han, H., Sung, J., Jung, H. O., et al. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01008-5 · Cited by 193
Localization of fat depots and cardiovascular risk
Gruzdeva, O. V., Borodkinа, D. A., Учасова, Е. Г., Dyleva, Y. A., & Барбараш, О. Л. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0856-8 · Cited by 195
Influenza Vaccine in Heart Failure
Modin, D., Jørgensen, M. E., Gislason, G., Jensen, J. S., Køber, L., Claggett, B. L., Hegde, S. M., Solomon, S. D., Torp-Pedersen, C. T., & Biering‐Sørensen, T. (2019) · Circulation · doi:10.1161/circulationaha.118.036788 · Cited by 178
Photoplethysmography and Deep Learning: Enhancing Hypertension Risk Stratification
Liang, Y., Chen, Z., Ward, R. K., & Elgendi, M. (2018) · Biosensors · doi:10.3390/bios8040101 · Cited by 176
DeFilippis, A. P., Young, R. L., McEvoy, J. W., Michos, E. D., Sandfort, V., Kronmal, R. A., McClelland, R. L., & Blaha, M. J. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw301 · Cited by 170
Comprehensive Metabolomic Profiling and Incident Cardiovascular Disease: A Systematic Review
Ruiz‐Canela, M., Hruby, A., Clish, C. B., Liang, L., Martínez‐González, M. Á., & Hu, F. B. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.005705 · Cited by 165
Prabhakaran, D., Anand, S., Watkins, D., Gaziano, T., Wu, Y., Mbanya, J. C., Nugent, R., Ajay, V. S., Afshin, A., Adler, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32471-6 · Cited by 162
Self-citationF. Piepoli, M. (2017) · International Journal of Behavioral Medicine · doi:10.1007/s12529-016-9583-6 · Cited by 162
Zhu, W., Buffa, J. A., Wang, Z., Warrier, M., Schugar, R., Shih, D. M., Gupta, N., Gregory, J. C., Org, E., Fu, X., et al. (2018) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14234 · Cited by 161
Bloomfield, H. E., Koeller, E., Greer, N., MacDonald, R., Kane, R., & Wilt, T. J. (2016) · Annals of Internal Medicine · doi:10.7326/m16-0361 · Cited by 159
Resource Effective Strategies to Prevent and Treat Cardiovascular Disease
Schwalm, J.-D., McKee, M., Huffman, M. D., & Yusuf, S. (2016) · Circulation · doi:10.1161/circulationaha.115.008721 · Cited by 155
The gut microbiota: An emerging risk factor for cardiovascular and cerebrovascular disease
Ascher, S., & Reinhardt, C. (2017) · European Journal of Immunology · doi:10.1002/eji.201646879 · Cited by 154
Effects of Interleukin 17 on the cardiovascular system
Robert, M., & Miossec, P. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.07.009 · Cited by 146
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M. T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · Kardiologia Polska · doi:10.5603/kp.2016.0120 · Cited by 152
Global trend of diabetes mortality attributed to vascular complications, 2000–2016
Ling, W., Huang, Y., Huang, Y., Fan, R., Sui, Y., & Zhao, H.-L. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01159-5 · Cited by 155
Kim, A. S., Cahill, E. A., & Cheng, N. T. (2015) · Stroke · doi:10.1161/strokeaha.115.008226 · Cited by 142
Periodontal Health and Disease in the Context of Systemic Diseases
Isola, G., Santonocito, S., Lupi, S. M., Polizzi, A., Sclafani, R., Patini, R., & Marchetti, E. (2023) · Mediators of Inflammation · doi:10.1155/2023/9720947 · Cited by 140
Michel Komajda, N., Böhm, M., BORER, J. S., Ford, I., Tavazzi, L., Pannaux, M., & Swedberg, K. B. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1234 · Cited by 142
Hirata, T., Arai, Y., Yuasa, S., Abe, Y., Takayama, M., Sasaki, T., Kunitomi, A., Inagaki, H., Endo, M., Morinaga, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17636-0 · Cited by 138
A general strategy of 3D printing thermosets for diverse applications
Lei, D., Yang, Y., Liu, Z., Chen, S., Song, B., Shen, A., Yang, B., Li, S., Yuan, Z., Qi, Q., et al. (2018) · Materials Horizons · doi:10.1039/c8mh00937f · Cited by 137
Chavez, J. D., Lee, C. F., Caudal, A., Keller, A., Tian, R., & Bruce, J. E. (2017) · Cell Systems · doi:10.1016/j.cels.2017.10.017 · Cited by 139
Guía ESC 2021 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2022) · Revista Española de Cardiología · doi:10.1016/j.recesp.2021.11.027 · Cited by 147
Limberg, J. K., Casey, D. P., Trinity, J. D., Nicholson, W. T., Wray, D. W., Tschakovsky, M. E., GREEN, D. J., Hellsten, Y., Fadel, P. J., Joyner, M. J., et al. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00649.2019 · Cited by 130
Sinha, S. S., Sjoding, M. W., Sukul, D., Prescott, H. C., Iwashyna, T. J., Gurm, H. S., Cooke, C. R., & Nallamothu, B. K. (2017) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.117.003616 · Cited by 130
Mendelian Randomization Study of PCSK9 and HMG-CoA Reductase Inhibition and Cognitive Function
Rosoff, D. B., Bell, A. S., Jung, J., Wagner, J., Mavromatis, L. A., & Lohoff, F. W. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.05.041 · Cited by 126
Roles of Phenolic Compounds in the Reduction of Risk Factors of Cardiovascular Diseases
Mariane Lutz, R., Eduardo Fuentes, Q., Ávila, F., Alarcón, M. A., & Palomo, I. F. (2019) · Molecules · doi:10.3390/molecules24020366 · Cited by 130
Rasmussen, K. L. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.10.037 · Cited by 125
Biomimetic nanoparticle technology for cardiovascular disease detection and treatment
Park, J. H., Dehaini, D., Zhou, J., Holay, M., Fang, R. H., & Zhang, L. (2019) · Nanoscale Horizons · doi:10.1039/c9nh00291j · Cited by 128
Mobile Phone Interventions for the Secondary Prevention of Cardiovascular Disease
Park, L. G., Beatty, A. L., Stafford, Z., & Whooley, M. A. (2016) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2016.03.002 · Cited by 130
Impact of Aging on Cardiovascular Diseases
Zhao, D. H., Wang, Y., Wong, N. D., & Wang, J. (2024) · JACC Asia · doi:10.1016/j.jacasi.2024.02.002 · Cited by 137
The High Cost of Stroke and Stroke Cytoprotection Research
Lapchak, P. A., & Zhang, J. H. (2016) · Translational Stroke Research · doi:10.1007/s12975-016-0518-y · Cited by 122
Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease
Ferrario, C. M., & Mullick, A. E. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.05.020 · Cited by 126
Modeling Future Cardiovascular Disease Mortality in the United States
Pearson‐Stuttard, J., Guzman-Castillo, M., Peñalvo, J. L., Rehm, C. D., Afshin, A., Danaei, G., Kypridemos, C., Gaziano, T., Mozaffarian, D., Capewell, S., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.019904 · Cited by 122
Indian guidelines on hypertension-IV (2019)
Shah, S. N., Munjal, Y. P., Kamath, S. A., Wander, G. S., Mehta, N., Mukherjee, S., Kirpalani, A. L., Gupta, P., Shah, H., Rohatgi, R., et al. (2020) · Journal of Human Hypertension · doi:10.1038/s41371-020-0349-x · Cited by 125
Adherence to the Mediterranean diet and risk of stroke and stroke subtypes
Chen, G., Neelakantan, N., Martín‐Calvo, N., Koh, W., Yuan, J., Bonaccio, M., Iacoviello, L., Martínez‐González, M. Á., Qin, L., & van Dam, R. M. (2019) · European Journal of Epidemiology · doi:10.1007/s10654-019-00504-7 · Cited by 122
Cardiovascular disease (CVD): assessment, prediction and policy implications
Rehman, S., Rehman, E., Ikram, M., & Jianglin, Z. (2021) · BMC Public Health · doi:10.1186/s12889-021-11334-2 · Cited by 118
Chan, N., & Weitz, J. I. (2019) · Circulation Research · doi:10.1161/circresaha.118.313155 · Cited by 120
Oral Microbiota: A Major Player in the Diagnosis of Systemic Diseases
Thomas, C., Minty, M., Vinel, A., Canceill, T., Loubières, P., Burcelin, R., Kaddech, M., Blasco‐Baqué, V., & Laurencin‐Dalicieux, S. (2021) · Diagnostics · doi:10.3390/diagnostics11081376 · Cited by 122
Chen, H., Li, M., Liu, L., Dang, X., Zhu, D., & Tian, G. (2019) · Medicine · doi:10.1097/md.0000000000016267 · Cited by 115
Hambleton, I. R., Caixeta, R. D. B., Jeyaseelan, S. M., Luciani, S., & Hennis, A. J. M. (2023) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2023.100483 · Cited by 114
A physiological characterization of the Cafeteria diet model of metabolic syndrome in the rat
Gomez-Smith, M., Karthikeyan, S., Jeffers, M. S., Janik, R., Thomason, L. A. M., Stefanovic, B., & Corbett, D. (2016) · Physiology & Behavior · doi:10.1016/j.physbeh.2016.09.029 · Cited by 115
Ma, Q., Fan, Q., Han, X., Dong, Z., Xu, J., Bai, J., Tao, W., Sun, D., & Wang, C. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.11.064 · Cited by 112
Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases
Bahiru, E. M., de Cates, A. N., Farr, M. R. B., Jarvis, M. C., Palla, M., Rees, K., Ebrahim, S. B. J., & Huffman, M. D. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009868.pub3 · Cited by 112
Ezetimibe for the prevention of cardiovascular disease and all-cause mortality events
Zhan, S., Tang, M., Liu, F., Xia, P., Shu, M., & Wu, X. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012502.pub2 · Cited by 109
Small-diameter hybrid vascular grafts composed of polycaprolactone and polydioxanone fibers
Pan, Y., Zhou, X., Wei, Y., Zhang, Q., Wang, T., Zhu, M., Li, W., Huang, R., Liu, R., Chen, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-03851-1 · Cited by 109
Metadata
- Authors
- Roth, G. A., Forouzanfar, M. H., Moran, A. E., Barber, R., Nguyen, G., Feigin, V. L., Naghavi, M., Mensah, G. A., & Murray, C. J. L.
- Affiliations
- National Institutes of Health (US)
- University of Washington (US)
- Columbia University (US)
- Auckland University of Technology (NZ)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-04-02
- Volume
- 372
- Issue
- 14
- Pages
- 1333-1341
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC4482354
- OpenAlex
- W1986019364
- Semantic Scholar
- 27a6b9a739f391969318dbfd3ffe6b84aa566d21
- Cited by
- 1,188
- References
- 14
- Citations by year
- 2026: 30 · 2025: 87 · 2024: 115 · 2023: 110 · 2022: 117 · 2021: 123 · 2020: 141 · 2019: 118 · 2018: 105 · 2017: 110 · 2016: 98 · 2015: 31
- FWCI
- 89.97
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (K08HL089675)
- Topics
- Health Sciences › Medicine › Epidemiology › Healthcare Systems and Public Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Social Sciences › Demography › Insurance, Mortality, Demography, Risk Management
- Keywords
- cardiovascular mortality, population aging, population growth, age-specific mortality, counterfactual scenarios, GDP per capita, global health trends, regional variation in mortality
- MeSH terms
- Age Factors, Cardiovascular Diseases, Demography, Humans, Income, Mortality, Sex Factors, Global Health
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
